Emerging Molecular Receptors for the Specific-Target Delivery of Ruthenium and Gold Complexes into Cancer Cells
Cisplatin and derivatives are highly effective in the treatment of a wide range of cancer types; however, these metallodrugs display low selectivity, leading to severe side effects. Additionally, their administration often results in the development of chemoresistance, which ultimately results in th...
Main Authors: | João Franco Machado, João D. G. Correia, Tânia S. Morais |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/11/3153 |
Similar Items
-
Revolutionizing Healthcare through Applications and Challenges of Nanomaterials in Targeted Drug Delivery and Therapeutics
by: Verma Rajan, et al.
Published: (2024-01-01) -
New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential
by: Ana Rita Brás, et al.
Published: (2023-06-01) -
Nanorobots mediated drug delivery for brain cancer active targeting and controllable therapeutics
by: Mengze Xu, et al.
Published: (2024-11-01) -
Review of Gold Nanoparticles: Synthesis, Properties, Shapes, Cellular Uptake, Targeting, Release Mechanisms and Applications in Drug Delivery and Therapy
by: Joel Georgeous, et al.
Published: (2024-10-01) -
Analytical chemistry of ruthenium/
by: 301464 Avtokratova, T. D.
Published: (1963)